U.S., May 19 -- ClinicalTrials.gov registry received information related to the study (NCT07594158) titled 'A Study to Evaluate the Safety, Efficacy, and PK of ONO-2017 in Japanese Patients With POS 2 to 17 Year Olds' on May 11.
Brief Summary: Primary objective: To evaluate the safety and tolerability of cenobamate in Japanese pediatric subjects 2-17 years of age with partial-onset (focal) seizures
Study Start Date: May 30
Study Type: INTERVENTIONAL
Condition:
Partial Epilepsy
Intervention:
DRUG: Cenobamate (tablet) for 12 to = 50 mg per day to establish the maintenance dose. In principle, all doses should be taken with an appropriate amount of water in the morning. The dosage form for the doses will be selected by the principal inve...